Get the latest Science News and Discoveries
Novel radiotracer rapidly detects gastrointestinal cancer biomarker, identifies patients for targeted therapy - EurekAlert
A new PET radiotracer enables same-day imaging of the important gastrointestinal cancer biomarker known as Claudin18.2 (CLDN18.2). Uptake of the radiotracer, 68Ga-NC-BCH, was found to correlate significantly with CLDN18.2 expression, a promising finding that could allow oncologists to optimize treatment for patients and monitor their response. This research was published in the June issue of The Journal of Nuclear Medicine.
None
Or read this on Eureka Alert